Facts on Drugs Used in Chemotherapy
Active substance: Paclitaxel
Manufacturer: Bristol-Myers Squibb
Extract from the prescribing information:
"Anaphylaxis and severe hypersensitivity reactions characterized by dyspnea and hypotension requiring treatment, angioedema, and generalized urticaria have occurred in 2 to 4% of patients receiving TAXOL in clinical trials. Fatal reactions have occurred in patients despite premedication."
The above has been extracted from the Taxol prescribing information on the Bristol-Myers Squibb webpages.